Vaccine adjuvants help to create a stronger immune response in the patient's body. People with low immune systems such as very young and elderly, will benefit from adjuvanted vaccines as their immune systems requires an extra boost in order to provide protection.
The global vaccine adjuvant market is expected to value at approximately US $ 0.5 in 2019, and is expected to be CAGR or 10.4%. The first five-year cumulative revenue (2018-2022) is projected to be more than US $ 3 Bn, which is expected to increase considerably over the laughter part of the five-year forecast period.
Increasing focus on improved and long-lasting vaccines for existing and emerging chronic diseases and increasing government expenditure on R&D of adjuvant vaccines, are major factors expected to drive the growth of the target market over the forecast period. In case of chronic infectious diseases and cancers, it can be difficult to develop an effective vaccine without blocking immune regulatory pathways and subsequently driving growth of the target market over the forecast period.
High requirement of vaccine adjuvants for pandemic diseases is a factor which creates a lucrative growth opportunity for manufacturers to drive the target market in the next coming years.
Global Vaccine Adjuvants Market: Market Forecast
The comprehensive research report includes a complete forecast of the global vaccine adjuvants market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global vaccine adjuvant market is expected to expand at a moderate CAGR or 10.4% during the forecast period.
Global Vaccine Adjuvants Market: Segmental Snapshot
By Product Type: The pathogen segment is projected to expand at a CAGR or over 10.4% over the forecast period
By Route of Administration: The intradermal segment is projected to register at CAGR or over 10.4% over the forecast period
By Disease Type: The cancer segment is projected to expand at a CAGR or over 10.4% in years to come
By Application: The commercial segment is projected to expand at a CAGR or over 10.3% over the forecast period
By Region: The market in Asia Pacific is projected to register highest CAGR or over 10.6% in the next coming years
Global Vaccine Adjuvants Market: Competitive Analysis
The research report on the global vaccine adjuvant market includes profiles of some of major companies such as Brenntag Biosector A / S, CSL Limited, Air Liquide SA, Agenus Inc., Novavax, Inc., Associated British Foods Plc (SPI Pharma, Inc. ), InvivoGen Inc., Avanti Polar Lipids, Inc., MVP Laboratories Inc., and OZ Biosciences.